Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Pilot Study of Tazemetostat and Pembrolizumab MK-3475 in Advanced Urothelial Carcinoma
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT03854474
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase I, Randomized, Dose and Schedule Evaluation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Belantamab Mafodotin Administered in Combination with Standard of Care in Participants with Newly Diagnosed Multiple Myeloma Pro00039777
A Randomized Phase II Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where cisplatin-Based Treatment is Not an Option
A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi- Regional, International Study of Durvalumab in Combination with Gemcitabine plus Cisplatin versus Placebo in Combination with Gemcitabine plus Cisplatin for Patients with First-Line Advanced Biliary Tract Cancers TOPAZ-1
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon alpha-2b for Resected High-Risk Melanoma.
A Phase II Open-Label Multicenter Study Evaluating The Safety And Efficacy Of Neoadjuvant And Adjuvant Tiragolumab Plus Atezolizumab With Or Without Platinum-Based Chemotherapy In Patients With Previously Untreated Locally Advanced Resectable Stage II, IIIa Or Select IIIb Non-Small Cell Lung Cancer
Study Type: Treatment
Phase: II
NCTID: NCT04832854
Principal Investigator:
Jun Zhang
A Phase I/IB First-In-Human Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics and Anti-Tumor Activity of SAR439459 Administered Intravenously as Monotherapy and in Combination with Cemiplimab in Adult Patients with Advanced Solid Tumors
Phase II Single Blind Randomized Trial Comparing Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy CRS-HIPEC using Mitomycin-C versus Melphalan for Colorectal Peritoneal Carcinomatosis ? A KUCC ? Funded Pilot Trial
Study Type: Treatment
Phase: II
NCTID: NCT03073694
Principal Investigator:
Mazin Al-Kasspooles